佛塑科技(000973.SZ):2019年度計提資產減值準備1.49億元
格隆匯3月25日丨佛塑科技(000973.SZ)公佈,根據《企業會計準則》等相關規定,公司對各類資產進行了全面清查。為了客觀、真實、準確地反映公司截至2019年12月31日的財務狀況、資產價值及經營情況,基於謹慎性原則,公司擬對可能發生資產減值損失的相關資產計提減值準備。經公司第十屆董事會第三次會議批准,公司已於2019年三季度計提資產減值準備3484.45萬元。此次2019年度計提資產減值準備的金額為1.49億元,涵蓋了上述2019年三季度計提資產減值準備金額。
此次計提信用減值損失及資產減值損失共計影響當期利潤1.49億元,其中影響母公司當期利潤4562.76萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.